Sfoglia per RIVISTA
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
Collezione ASL Asti

  

Items : 8

Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2025 Feb 6;209:104627. doi: 10.1016/j.critrevonc.2025.104627.

2025
AOU San Luigi di Orbassano
ASL Torino 3
ASL Asti

Colombo C; De Leo S; Campisi I; Palesandro E; Turco F; Buttigliero C; Fugazzola L; Tucci M;

A new era for radium-223? Optimizing treatment by balancing efficacy and toxicity through combination therapies in Critical Reviews in Oncology/Hematology

2025
ASL Asti

Farinea G; Cozzone L; Butticè S; Mogavero A; Di Stefano RF; Angusti T; Parente A; Tucci M; Buttigliero C;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24

2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Brusa F; Audisio A; Di Stefano RF; Ungaro A; Audisio M; Samuelly A; Turco F; Tucci M; Delcuratolo MD;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Di Stefano RF; Parlagreco E; Tucci M; Audisio M;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19

2022
ASL Asti
AOU San Luigi di Orbassano

Passiglia F; Novello S; Buffoni L; Carnio S; Capelletto E; Zichi C; Reale ML; Artusio E; Olmetto E; Bungaro M; Paratore C; Bertaglia V; Audisio M; Rapetti SG; Pignataro D; Curcio H; De Luca E; Bironzo P; Tagliamento M; Scagliotti GV; Di Maio M;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27

2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Pisano C; Tucci M; Di Stefano RF; Turco F; Scagliotti GV; Di Maio M;

Exploring the role of respiratory microbiome in lung cancer: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Aug;164:103404. doi: 10.1016/j.critrevonc.2021.103404. Epub 2021 Jun 29

2021
ASL Asti
AOU San Luigi di Orbassano

Galetta D; Tiseo M; Menis J; Facchinetti F; Bironzo P; Sartori G; Russano M; Rinaldi S; Prelaj A; Pignataro D; Montrone M; Meacci F; Di Noia V; Bianconi M; Mazzotta M; Perrone F; Belluomini L; Novello S; Pilotto S;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24

2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Di Maio M; Scagliotti GV; Vignani F; Tabbò F; Turco F; Di Stefano RF; Buttigliero C; Pisano C; Leone G;